Evidence map›Paper›PMID 38968111›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Attenuating midline thalamus bursting to mitigate absence epilepsy.

Ping Dong, Konstantin Bakhurin, Yuhui Li, Mohamad A Mikati, Jianmin Cui, Warren M Grill, Henry H Yin, Huanghe Yang

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ping DongDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710.ORCID 0000-0002-6640-6607
Konstantin BakhurinDepartment of Psychology and Neuroscience, Duke University, Durham, NC 27708.
Yuhui LiDepartment of Biomedical Engineering, Duke University, Durham, NC 27708.ORCID 0000-0002-5351-7703
Mohamad A MikatiDepartment of Neurobiology, Duke University Medical Center, Durham, NC 27710.ORCID 0000-0003-0363-8715
Jianmin CuiDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130.ORCID 0000-0002-9198-6332
Warren M GrillDepartment of Biomedical Engineering, Duke University, Durham, NC 27708.ORCID 0000-0001-5240-6588
Henry H YinDepartment of Psychology and Neuroscience, Duke University, Durham, NC 27708.ORCID 0000-0003-1546-6850
Huanghe YangDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710.ORCID 0000-0001-9521-9328

Funding

American Epilepsy Society (AES) 693905DU | Duke Institute for Brain Sciences, Duke University (DIBS) Incubator AwardHolland-Trice Foundation Holland-Trice Award
6 · The paper itself

Abstract

Advancing the mechanistic understanding of absence epilepsy is crucial for developing new therapeutics, especially for patients unresponsive to current treatments. Utilizing a recently developed mouse model of absence epilepsy carrying the BK gain-of-function channelopathy D434G, here we report that attenuating the burst firing of midline thalamus (MLT) neurons effectively prevents absence seizures. We found that enhanced BK channel activity in the BK-D434G MLT neurons promotes synchronized bursting during the ictal phase of absence seizures. Modulating MLT neurons through pharmacological reagents, optogenetic stimulation, or deep brain stimulation effectively attenuates burst firing, leading to reduced absence seizure frequency and increased vigilance. Additionally, enhancing vigilance by amphetamine, a stimulant medication, or physical perturbation also effectively suppresses MLT bursting and prevents absence seizures. These findings suggest that the MLT is a promising target for clinical interventions. Our diverse approaches offer valuable insights for developing next generation therapeutics to treat absence epilepsy.

Indexed as

Disease Models, AnimalEpilepsy, AbsenceAnimalsDeep Brain StimulationLarge-Conductance Calcium-Activated Potassium ChannelsMaleMiceMidline Thalamic NucleiNeuronsOptogeneticsThalamusLarge-Conductance Calcium-Activated Potassium Channelsabsence seizureBK channelopathyepilepsymidline thalamusthalamus

Identifiers

PMID38968111
PMCPMC11252967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.